Literature DB >> 17196359

Prospective determinants of smoking cessation in COPD patients within a high intensity or a brief counseling intervention.

Lieke Christenhusz1, Marcel Pieterse, Erwin Seydel, Job van der Palen.   

Abstract

OBJECTIVES: The aims of this study were to identify prospective determinants of smoking cessation in COPD patients, and to assess whether prospective determinants vary between two different cessation interventions.
METHODS: Two hundred and twenty-five moderate to severe COPD patients were randomly allocated to two smoking cessation interventions. One-year cotinine-validated continuous abstinence rates were 9% for the minimal intervention strategy for lung patients (LMIS) and 19% for the SmokeStopTherapy (SST). The baseline characteristics that showed a significant univariate relationship with 1-year continuous abstinence (p<.20) were included in the logistic regression model. This procedure was performed for each intervention separately. Variables that did not remain independent predictors were removed.
RESULTS: For the SST separately, no independent significant predictor remained. For the LMIS, attitude towards smoking cessation (OR: 11.8; 95% CI: 1.7-81.5; p=.013) and cotinine level (OR: 2.1; 95% CI: 1.08-3.93; p=.028) remained significant predictors. Within the LMIS, 31% of the variance in continuous abstinence was explained by these variables (p=.003).
CONCLUSION: This study suggests that a moderately intensive intervention (LMIS) is primarily suitable for COPD patients with a positive attitude regarding smoking cessation. The more intensive SST can be an alternative for patients without such baseline characteristic. PRACTICE IMPLICATIONS: This stepped-care approach in smoking cessation counseling may be useful in clinical practice and will enable health care providers to match interventions to individual needs and increase efficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196359     DOI: 10.1016/j.pec.2006.11.006

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  7 in total

1.  Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions.

Authors:  Rilana Prenger; Marcel E Pieterse; Louise M A Braakman-Jansen; Job van der Palen; Lieke C A Christenhusz; Erwin R Seydel
Journal:  Eur J Health Econ       Date:  2012-01-06

2.  The Difference a Decade Makes: Smoking Cessation Counseling and Screening at Pediatric Visits.

Authors:  Philip B Cawkwell; Lily Lee; Jenni Shearston; Scott E Sherman; Michael Weitzman
Journal:  Nicotine Tob Res       Date:  2016-07-11       Impact factor: 4.244

3.  Effective smoking cessation interventions for COPD patients: a review of the evidence.

Authors:  Sophie Coronini-Cronberg; Catherine Heffernan; Michael Robinson
Journal:  JRSM Short Rep       Date:  2011-10-14

4.  Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Bosun Hong; Jonathan Livingstone-Banks; Hannah Wheat; Thomas R Fanshawe
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

5.  Study protocol for a non-inferiority trial of a blended smoking cessation treatment versus face-to-face treatment (LiveSmokefree-Study).

Authors:  Lutz Siemer; Marcel E Pieterse; Marjolein G J Brusse-Keizer; Marloes G Postel; Somaya Ben Allouch; Robbert Sanderman
Journal:  BMC Public Health       Date:  2016-11-24       Impact factor: 3.295

Review 6.  Counseling for health behavior change in people with COPD: systematic review.

Authors:  Marie T Williams; Tanja W Effing; Catherine Paquet; Carole A Gibbs; Hayley Lewthwaite; Lok Sze Katrina Li; Anna C Phillips; Kylie N Johnston
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-26

7.  Effectiveness of intensive smoking reduction counselling plus combination nicotine replacement therapy in promoting long-term abstinence in patients with chronic obstructive pulmonary disease not ready to quit smoking: Protocol of the REDUQ trial.

Authors:  Petra Hagens; Marcel Pieterse; Paul van der Valk; Job van der Palen
Journal:  Contemp Clin Trials Commun       Date:  2017-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.